Zydus In-Licensees Enoxaparin In US As It Plots $250m Injectables Business

Struck License And Supply Agreement With Italfarmaco Group’s Chemi

 
• By Dean Rudge
  
partnering
Chemi will manufacture the product and Zydus will commercialize it • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business